[go: up one dir, main page]

EP1556490A4 - NEW NUCLEIC ACIDS AND POLYPEPTIDES - Google Patents

NEW NUCLEIC ACIDS AND POLYPEPTIDES

Info

Publication number
EP1556490A4
EP1556490A4 EP03815295A EP03815295A EP1556490A4 EP 1556490 A4 EP1556490 A4 EP 1556490A4 EP 03815295 A EP03815295 A EP 03815295A EP 03815295 A EP03815295 A EP 03815295A EP 1556490 A4 EP1556490 A4 EP 1556490A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03815295A
Other languages
German (de)
French (fr)
Other versions
EP1556490A2 (en
Inventor
Y Tom Tang
Vinod Asundi
Feiyan Ren
Jie Zhang
Tom Wehrman
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Gezhi Weng
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1556490A2 publication Critical patent/EP1556490A2/en
Publication of EP1556490A4 publication Critical patent/EP1556490A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP03815295A 2002-10-22 2003-09-30 NEW NUCLEIC ACIDS AND POLYPEPTIDES Withdrawn EP1556490A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US416186P 2002-10-02
US41618602P 2002-10-22 2002-10-22
PCT/US2003/030720 WO2004080148A2 (en) 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1556490A2 EP1556490A2 (en) 2005-07-27
EP1556490A4 true EP1556490A4 (en) 2006-04-05

Family

ID=32990311

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03815295A Withdrawn EP1556490A4 (en) 2002-10-22 2003-09-30 NEW NUCLEIC ACIDS AND POLYPEPTIDES

Country Status (5)

Country Link
EP (1) EP1556490A4 (en)
JP (1) JP2006517094A (en)
AU (1) AU2003303305A1 (en)
CA (1) CA2500521A1 (en)
WO (1) WO2004080148A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209884D0 (en) 2002-04-30 2002-06-05 Ares Trading Sa Proteins
US20070037204A1 (en) * 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
JP4643450B2 (en) * 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス Cancer high expression gene
US7534562B2 (en) 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
EP1673475B1 (en) 2003-10-10 2010-04-28 Deutsches Krebsforschungszentrum Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
WO2005042770A2 (en) * 2003-11-03 2005-05-12 Ethicon, Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
GB0326393D0 (en) 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
WO2005070964A1 (en) * 2004-01-27 2005-08-04 Medical And Biological Laboratories Co., Ltd. Method of isolating monocytes
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
ZA200606461B (en) * 2004-02-12 2008-02-27 Lexicon Pharmaceuticals Inc Gene disruptions, compositions and methods relating thereto
US7425445B2 (en) * 2004-06-18 2008-09-16 Duke University Modulators that promote cell surface expression of odorant receptors
EP2287310B1 (en) * 2004-07-22 2015-05-06 Five Prime Therapeutics, Inc. Compositions and methods using MGD-CSF in disease treatment
US20090087474A1 (en) * 2005-01-07 2009-04-02 Petersen Thomas N Therapeutic use of growth factors,nsg29 and nsg31
GB0517466D0 (en) * 2005-08-26 2005-10-05 Immunodiagnostic Systems Plc Diagnostic assay and therapeutic treatment
HUE027179T2 (en) 2006-10-20 2016-10-28 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Rspondins as modulators of angiogenesis and vasculogenesis
US20100297623A1 (en) * 2007-03-07 2010-11-25 The Council Of The Queensland Institute Of Medical Research NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
WO2009025117A1 (en) 2007-08-20 2009-02-26 Oncotherapy Science, Inc. Cdca1 peptide and pharmaceutical agent comprising the same
JP5496897B2 (en) 2007-10-04 2014-05-21 ザイモジェネティクス， インコーポレイテッド B7 family member zB7H6 and related compositions and methods
US8410068B2 (en) 2007-10-05 2013-04-02 Index Pharmaceuticals Ab Compounds for the treatment or alleviation of edema, and methods for their use
US9249409B2 (en) * 2007-10-25 2016-02-02 Toray Industries, Inc. Method for detection of cancer
KR101692820B1 (en) * 2007-10-25 2017-01-05 도레이 카부시키가이샤 Immune response inducer
JP5572938B2 (en) * 2007-10-25 2014-08-20 東レ株式会社 Immune inducer
US8198406B2 (en) * 2007-11-07 2012-06-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US9096689B2 (en) * 2007-11-07 2015-08-04 Northwestern University Methods and compositions for inhibiting angiogenesis
WO2009086106A1 (en) * 2007-12-21 2009-07-09 Mount Sinai School Of Medicine Of New York University Use of podocan protein in treating cardiovascular diseases
TWI526219B (en) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Cdca1 epitope peptides and vaccines containing the same
WO2014010229A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Cdca1 epitope peptides for th1 cells and vaccines containing the same
AU2013364043B2 (en) 2012-12-21 2018-01-04 Seagen Inc. Anti-NTB-A antibodies and related compositions and methods
DK3322733T3 (en) * 2015-07-13 2021-10-18 Compugen Ltd HIDE1 COMPOSITIONS AND METHODS
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN106047818A (en) * 2016-08-05 2016-10-26 武汉赛云博生物科技有限公司 Oncofetal antigen-specific TCR gene-modified T cell and cancer inhibition use thereof
TW202023581A (en) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 Cdca1-derived peptide and vaccine containing same
EP3891123A4 (en) 2018-12-03 2022-12-14 Board of Regents, The University of Texas System OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN THE TREATMENT OF CANCER

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090366A2 (en) * 2000-05-24 2001-11-29 Curagen Corporation Human polynucleotides and polypeptides encoded thereby

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090366A2 (en) * 2000-05-24 2001-11-29 Curagen Corporation Human polynucleotides and polypeptides encoded thereby

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 29 January 2002 (2002-01-29), "Homo sapiens BAC clone RP11-386I19 from 4, complete sequence.", XP002354641, retrieved from EBI accession no. EM_PRO:AC108139 Database accession no. AC108139 *
THE SANGER CENTRE (UK) AND THE WASHINGTON UNIVERSITY GENOME SEQUENCING CENTER (USA): "Toward a complete human genome sequence", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 8, no. 11, November 1998 (1998-11-01), pages 1097 - 1108, XP002169000, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
CA2500521A1 (en) 2004-09-23
EP1556490A2 (en) 2005-07-27
JP2006517094A (en) 2006-07-20
AU2003303305A1 (en) 2004-09-30
WO2004080148A3 (en) 2005-03-31
WO2004080148A2 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
EP1556490A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1504099A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1432800A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1325120A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1341804A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1242443A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1368475A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
ATE554171T1 (en) RECEPTOR NUCLEIC ACIDS AND POLYPEPTIDES
EP1276751A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1381621A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1470238A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
AU2003226416A8 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
EP1483386A4 (en) NEW NUCLEIC ACIDS AND SPECIFIC POLYPEPTIDES
EP1430112A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1451217A4 (en) Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
EP1341803A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1565553A4 (en) Recombinant catalytic polypeptides and their uses
EP1359932A4 (en) TIP39 POLYPEPTIDE
EP1282635A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1268762A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1370675A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
DE60028365D1 (en) CHIMERIC NUCLEIC ACIDS AND POLYPEPTIDES FROM LYSSAVIRUS
DE60217711D1 (en) PTP10D NUCLEIC ACIDS AND PEPTIDES IN THE REGULATION OF ENERGY HOMEOSTASIS
AU2003207606A8 (en) Sqv nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050427

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20060221

17Q First examination report despatched

Effective date: 20061207

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070418